Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parkinson's Disease
  Free Subscription

Articles published in
Neurobiol Dis
    May 2024
  1. HEMBACH S, Schmidt S, Orschmann T, Burtscher I, et al
    Engrailed 1 deficiency induces changes in ciliogenesis during human neuronal differentiation.
    Neurobiol Dis. 2024;194:106474.
    >> Share

    April 2024
  2. TREMBLAY C, Aslam S, Walker JE, Lorenzini I, et al
    RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction.
    Neurobiol Dis. 2024 Apr 23:106514. doi: 10.1016/j.nbd.2024.106514.
    >> Share

  3. BUOSO C, Seifert M, Lang M, Griffith CM, et al
    Dopamine?iron homeostasis interaction rescues mitochondrial fitness in Parkinson's disease.
    Neurobiol Dis. 2024 Apr 20:106506. doi: 10.1016/j.nbd.2024.106506.
    >> Share

  4. TONG B, Ba Y, Li Z, Yang C, et al
    Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
    Neurobiol Dis. 2024 Apr 18:106505. doi: 10.1016/j.nbd.2024.106505.
    >> Share

  5. JIAO LL, Dong HL, Liu MM, Wu PL, et al
    The potential roles of salivary biomarkers in neurodegenerative diseases.
    Neurobiol Dis. 2024;193:106442.
    >> Share

    March 2024
  6. IOVINO L, Vander Zwaag J, Kaur G, Khakpour M, et al
    Investigation of microglial diversity in a LRRK2 G2019S mouse model of Parkinson's disease.
    Neurobiol Dis. 2024 Mar 23:106481. doi: 10.1016/j.nbd.2024.106481.
    >> Share

  7. ZHOU C, You J, Guan X, Guo T, et al
    Microstructural alterations of the hypothalamus in Parkinson's disease and probable REM sleep behavior disorder.
    Neurobiol Dis. 2024 Mar 11:106472. doi: 10.1016/j.nbd.2024.106472.
    >> Share

    February 2024
  8. HUANG YT, Chen YW, Lin TY, Chen JC, et al
    Suppression of presynaptic corticostriatal glutamate activity attenuates L-dopa-induced dyskinesia in 6-OHDA-lesioned Parkinson's disease mice.
    Neurobiol Dis. 2024;193:106452.
    >> Share

  9. STOLL AC, Kemp CJ, Patterson JR, Howe JW, et al
    Neuroinflammatory gene expression profiles of reactive glia in the substantia nigra suggest a multidimensional immune response to alpha synuclein inclusions.
    Neurobiol Dis. 2024;191:106411.
    >> Share

    January 2024
  10. IMARISIO A, Yahyavi I, Avenali M, Di Maio A, et al
    Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease.
    Neurobiol Dis. 2024;192:106413.
    >> Share

  11. WU C, Wu H, Zhou C, Guan X, et al
    Neurovascular coupling alteration in drug-naive Parkinson's disease: The underlying molecular mechanisms and levodopa's restoration effects.
    Neurobiol Dis. 2024 Jan 8:106406. doi: 10.1016/j.nbd.2024.106406.
    >> Share

  12. SALIN P, Melon C, Chassain C, Gubellini P, et al
    Interhemispheric reactivity of the subthalamic nucleus sustains progressive dopamine neuron loss in asymmetrical parkinsonism.
    Neurobiol Dis. 2024;191:106398.
    >> Share

    December 2023
  13. TRAN S, Heida TC, Heijs JJA, Al-Ozzi T, et al
    Subthalamic and pallidal neurons are modulated during externally cued movements in Parkinson's disease.
    Neurobiol Dis. 2023 Dec 20:106384. doi: 10.1016/j.nbd.2023.106384.
    >> Share

  14. LIANG K, Li X, Guo Q, Ma J, et al
    Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
    Neurobiol Dis. 2023;190:106379.
    >> Share

  15. DI LAZZARO G, Picca A, Boldrini S, Bove F, et al
    Differential profiles of serum cytokines in Parkinson's disease according to disease duration.
    Neurobiol Dis. 2023 Dec 5:106371. doi: 10.1016/j.nbd.2023.106371.
    >> Share

    November 2023
  16. TSHILENGE KT, Bons J, Aguirre CG, Geronimo-Olvera C, et al
    Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
    Neurobiol Dis. 2023 Nov 30:106367. doi: 10.1016/j.nbd.2023.106367.
    >> Share

  17. TOFFOLI M, Chohan H, Mullin S, Jesuthasan A, et al
    Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study.
    Neurobiol Dis. 2023 Nov 3:106343. doi: 10.1016/j.nbd.2023.106343.
    >> Share

  18. HARVEY J, Pishva E, Chouliaras L, Lunnon K, et al
    Elucidating distinct molecular signatures of Lewy body dementias.
    Neurobiol Dis. 2023;188:106337.
    >> Share

  19. TUBERT C, Zampese E, Pancani T, Tkatch T, et al
    Feed-forward metabotropic signaling by Cav1 Ca(2+) channels supports pacemaking in pedunculopontine cholinergic neurons.
    Neurobiol Dis. 2023;188:106328.
    >> Share

  20. DUES DJ, Ma Y, Nguyen APT, Offerman AV, et al
    Formation of templated inclusions in a forebrain alpha-synuclein mouse model is independent of LRRK2.
    Neurobiol Dis. 2023;188:106338.
    >> Share

    October 2023
  21. RIVAS-SANTISTEBAN R, Rico A, Munoz A, Rodriguez AI, et al
    Boolean analysis shows a high proportion of dopamine D(2) receptors interacting with adenosine A(2A) receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease.
    Neurobiol Dis. 2023 Oct 31:106341. doi: 10.1016/j.nbd.2023.106341.
    >> Share

  22. CHEN L, Sun J, Gao L, Wang J, et al
    Dysconnectivity of the parafascicular nucleus in Parkinson's disease: A dynamic causal modeling analysis.
    Neurobiol Dis. 2023;188:106335.
    >> Share

  23. LI T, Liu T, Zhang J, Ma Y, et al
    Neurovascular coupling dysfunction of visual network organization in Parkinson's disease.
    Neurobiol Dis. 2023;188:106323.
    >> Share

  24. MAPLE-GRODEM J, Ushakova A, Pedersen KF, Tysnes OB, et al
    Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach.
    Neurobiol Dis. 2023;186:106281.
    >> Share

  25. SCHAFFNER SL, Wassouf Z, Hentrich T, Nuesch-Germano M, et al
    Distinct impacts of alpha-synuclein overexpression on the hippocampal epigenome of mice in standard and enriched environments.
    Neurobiol Dis. 2023;186:106274.
    >> Share

    September 2023
  26. DE FABREGUES O, Selles M, Ramos-Vicente D, Roch G, et al
    Relevance of tissue-resident memory CD8 T cells in the onset of Parkinson's disease and examination of its possible etiologies: infectious or autoimmune?
    Neurobiol Dis. 2023 Sep 21:106308. doi: 10.1016/j.nbd.2023.106308.
    >> Share

  27. TRINH D, Israwi AR, Brar H, Villafuerte JEA, et al
    Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy.
    Neurobiol Dis. 2023 Sep 11:106287. doi: 10.1016/j.nbd.2023.106287.
    >> Share

    August 2023
  28. GRONLIER E, Volle J, Coizet V, Paccard A, et al
    Evoked responses to single pulse electrical stimulation reveal impaired striatal excitability in a rat model of Parkinson's disease.
    Neurobiol Dis. 2023 Aug 19:106266. doi: 10.1016/j.nbd.2023.106266.
    >> Share

  29. GAN C, Ji M, Sun H, Cao X, et al
    Dynamic functional connectivity reveals hyper-connected pattern and abnormal variability in freezing of gait of Parkinson's disease.
    Neurobiol Dis. 2023;185:106265.
    >> Share

  30. REN J, Yan L, Zhou H, Pan C, et al
    Unraveling neurotransmitter changes in de novo GBA-related and idiopathic Parkinson's disease.
    Neurobiol Dis. 2023 Aug 7:106254. doi: 10.1016/j.nbd.2023.106254.
    >> Share

  31. DUMONT M, Agostinis A, Singh K, Swan E, et al
    Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies.
    Neurobiol Dis. 2023;184:106214.
    >> Share

  32. BHATIA TN, Jamenis AS, Abbas M, Clark RN, et al
    A 14-day pulse of PLX5622 modifies alpha-synucleinopathy in preformed fibril-infused aged mice of both sexes.
    Neurobiol Dis. 2023;184:106196.
    >> Share

    July 2023
  33. CROCKETT RA, Wilkins KB, Aditham S, Bronte-Stewart HM, et al
    No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment.
    Neurobiol Dis. 2023 Jul 29:106243. doi: 10.1016/j.nbd.2023.106243.
    >> Share

  34. URSO D, Batzu L, Logroscino G, Chaudhuri KR, et al
    Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease.
    Neurobiol Dis. 2023 Jul 25:106237. doi: 10.1016/j.nbd.2023.106237.
    >> Share

  35. AVANTAGGIATO F, Farokhniaee A, Bandini A, Palmisano C, et al
    Intelligibility of speech in Parkinson's disease relies on anatomically segregated subthalamic beta oscillations.
    Neurobiol Dis. 2023 Jul 25:106239. doi: 10.1016/j.nbd.2023.106239.
    >> Share

  36. WANG Y, Xia Y, Kou L, Yin S, et al
    Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease.
    Neurobiol Dis. 2023 Jul 9:106224. doi: 10.1016/j.nbd.2023.106224.
    >> Share

  37. LEGAZ A, Prado P, Moguilner S, Baez S, et al
    Social and non-social working memory in neurodegeneration.
    Neurobiol Dis. 2023;183:106171.
    >> Share

    June 2023
  38. WU H, Wu C, Qin J, Zhou C, et al
    Functional connectome predicting individual gait function and its relationship with molecular architecture in Parkinson's disease.
    Neurobiol Dis. 2023;184:106216.
    >> Share

  39. DI MAIO A, Nuzzo T, Gilio L, Serra M, et al
    Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
    Neurobiol Dis. 2023 Jun 17:106203. doi: 10.1016/j.nbd.2023.106203.
    >> Share

  40. BATZU L, Urso D, Grothe MJ, Vereb D, et al
    Increased basal forebrain volumes could prevent cognitive decline in LRRK2 Parkinson's disease.
    Neurobiol Dis. 2023 Jun 5:106182. doi: 10.1016/j.nbd.2023.106182.
    >> Share

  41. ZHONG M, Wang Y, Lin G, Liao FF, et al
    Dopamine-independent development and maintenance of mouse striatal medium spiny neuron dendritic spines.
    Neurobiol Dis. 2023;181:106096.
    >> Share

    May 2023
  42. LUCHETTI S, Liere P, Pianos A, Verwer RWH, et al
    Disease stage-dependent changes in brain levels and neuroprotective effects of neuroactive steroids in Parkinson's disease.
    Neurobiol Dis. 2023 May 29:106169. doi: 10.1016/j.nbd.2023.106169.
    >> Share

  43. YIN Z, Jiang Y, Merk T, Neumann WJ, et al
    Pallidal activities during sleep and sleep decoding in dystonia, Huntington's, and Parkinson's disease.
    Neurobiol Dis. 2023 May 3:106143. doi: 10.1016/j.nbd.2023.106143.
    >> Share

  44. FAYARD A, Fenyi A, Lavisse S, Dovero S, et al
    Functional and neuropathological changes induced by injection of distinct alpha-synuclein strains: A pilot study in non-human primates.
    Neurobiol Dis. 2023;180:106086.
    >> Share

  45. CHEN Z, Reynolds RH, Pardinas AF, Gagliano Taliun SA, et al
    The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases.
    Neurobiol Dis. 2023;180:106082.
    >> Share

    April 2023
  46. GUERRA A, Colella D, Cannavacciuolo A, Giangrosso M, et al
    Short-term plasticity of the motor cortex compensates for bradykinesia in Parkinson's disease.
    Neurobiol Dis. 2023;182:106137.
    >> Share

  47. HAYLEY S, Vahid-Ansari F, Sun H, Albert PR, et al
    Mood disturbances in Parkinson's disease: From prodromal origins to application of animal models.
    Neurobiol Dis. 2023 Apr 8:106115. doi: 10.1016/j.nbd.2023.106115.
    >> Share

  48. SASIKUMAR S, Sorrento G, Lang AE, Strafella AP, et al
    Cognition affects gait adaptation after split-belt treadmill training in Parkinson's disease.
    Neurobiol Dis. 2023 Apr 3:106109. doi: 10.1016/j.nbd.2023.106109.
    >> Share

    March 2023
  49. CAULFIELD ME, Vander Werp MJ, Stancati JA, Collier TJ, et al
    Downregulation of striatal Ca(V)1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age.
    Neurobiol Dis. 2023 Mar 29:106111. doi: 10.1016/j.nbd.2023.106111.
    >> Share

  50. HUANG Q, Chen C, Chen W, Cai C, et al
    Cell type- and region-specific translatomes in an MPTP mouse model of Parkinson's disease.
    Neurobiol Dis. 2023;180:106105.
    >> Share

  51. TAN S, Zhou C, Wen J, Duanmu X, et al
    Presence but not the timing of onset of REM sleep behavior disorder distinguishes evolution patterns in Parkinson's disease.
    Neurobiol Dis. 2023;180:106084.
    >> Share

  52. PORRINI V, Pilotto A, Vezzoli M, Lanzillotta A, et al
    NF-kappaB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients.
    Neurobiol Dis. 2023 Mar 7:106067. doi: 10.1016/j.nbd.2023.106067.
    >> Share

  53. WIEST C, He S, Duchet B, Pogosyan A, et al
    Evoked resonant neural activity in subthalamic local field potentials reflects basal ganglia network dynamics.
    Neurobiol Dis. 2023;178:106019.
    >> Share

  54. LIN S, Leitao ADG, Fang S, Gu Y, et al
    Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy.
    Neurobiol Dis. 2023;178:106010.
    >> Share

    February 2023
  55. MCKAY JL, Nye J, Goldstein FC, Sommerfeld B, et al
    Levodopa responsive freezing of gait is associated with reduced norepinephrine transporter binding in Parkinson's disease.
    Neurobiol Dis. 2023 Feb 20:106048. doi: 10.1016/j.nbd.2023.106048.
    >> Share

    January 2023
  56. ABDI IY, Bartl M, Dakna M, Abdesselem H, et al
    Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naive patients vs healthy controls with longitudinal clinical follow-up.
    Neurobiol Dis. 2023 Jan 9:105997. doi: 10.1016/j.nbd.2023.105997.
    >> Share

  57. OUTEIRO TF, El-Agnaf OM
    The immune system in Parkinson's disease: From biology to diagnosis and therapeutic targets.
    Neurobiol Dis. 2023 Jan 7:105995. doi: 10.1016/j.nbd.2023.105995.
    >> Share

  58. MARTEL AC, Galvan A
    Corrigendum to: "Connectivity of the Corticostriatal and Thalamostriatal Systems in Normal and Parkinsonian States: An Update" Neurobiology of Disease 174: 105878.
    Neurobiol Dis. 2023 Jan 2:105985. doi: 10.1016/j.nbd.2022.105985.
    >> Share

  59. ESTAUN-PANZANO J, Arotcarena ML, Bezard E
    Monitoring alpha-synuclein aggregation.
    Neurobiol Dis. 2023;176:105966.
    >> Share

  60. DE LAZZARI F, Agostini F, Plotegher N, Sandre M, et al
    DJ-1 promotes energy balance by regulating both mitochondrial and autophagic homeostasis.
    Neurobiol Dis. 2023;176:105941.
    >> Share

  61. CASTELA I, Casado-Polanco R, Rubio YV, da Silva JA, et al
    Selective activation of striatal indirect pathway suppresses levodopa induced-dyskinesias.
    Neurobiol Dis. 2023;176:105930.
    >> Share

    December 2022
  62. LEWITT PA, Li J, Wu KH, Lu M, et al
    Diagnostic metabolomic profiling of Parkinson's disease biospecimens.
    Neurobiol Dis. 2022 Dec 20:105962. doi: 10.1016/j.nbd.2022.105962.
    >> Share

  63. BRENDZA R, Gao X, Stark KL, Lin H, et al
    Anti-alpha-synuclein c-terminal antibodies block PFF uptake and accumulation of phospho-synuclein in preclinical models of Parkinson's disease.
    Neurobiol Dis. 2022 Dec 16:105969. doi: 10.1016/j.nbd.2022.105969.
    >> Share

  64. LIPARI N, Centner A, Glinski J, Cohen S, et al
    Characterizing the relationship between L-DOPA-induced-dyskinesia and psychosis-like behaviors in a bilateral rat model of Parkinson's disease.
    Neurobiol Dis. 2022;176:105965.
    >> Share

  65. VERMA AK, Yu Y, Acosta-Lenis SF, Havel T, et al
    Parkinsonian daytime sleep-wake classification using deep brain stimulation lead recordings.
    Neurobiol Dis. 2022 Dec 12:105963. doi: 10.1016/j.nbd.2022.105963.
    >> Share

  66. MELONI M, Agliardi C, Guerini FR, Zanzottera M, et al
    Oligomeric alpha-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms.
    Neurobiol Dis. 2022 Dec 5:105947. doi: 10.1016/j.nbd.2022.105947.
    >> Share

  67. GOPINATH A, Mackie PM, Phan LT, Tansey MG, et al
    The complex role of inflammation and gliotransmitters in Parkinson's disease.
    Neurobiol Dis. 2022 Dec 2:105940. doi: 10.1016/j.nbd.2022.105940.
    >> Share

  68. GAERTNER Z, Azcorra M, Dombeck DA, Awatramani R, et al
    Molecular heterogeneity in the substantia nigra: A roadmap for understanding PD motor pathophysiology.
    Neurobiol Dis. 2022;175:105925.
    >> Share

  69. TAI CH, Tseng SH
    Cerebellar deep brain stimulation for movement disorders.
    Neurobiol Dis. 2022;175:105899.
    >> Share

    November 2022
  70. WISE RM, Wagener A, Fietzek UM, Klopstock T, et al
    Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders.
    Neurobiol Dis. 2022;175:105920.
    >> Share

  71. SARKAR S
    Microglial ion channels: Key players in non-cell autonomous neurodegeneration.
    Neurobiol Dis. 2022;174:105861.
    >> Share

    October 2022
  72. CHO E, Kim K, Kim H, Cho SR, et al
    Reelin protects against pathological alpha-synuclein accumulation and dopaminergic neurodegeneration after environmental enrichment in Parkinson's disease.
    Neurobiol Dis. 2022 Oct 18:105898. doi: 10.1016/j.nbd.2022.105898.
    >> Share

  73. PUIGROS M, Calderon A, Perez-Soriano A, de Dios C, et al
    Cell-free mitochondrial DNA deletions in idiopathic, but not LRRK2, Parkinson's disease.
    Neurobiol Dis. 2022;174:105885.
    >> Share

  74. RYU DW, Yoo SW, Oh YS, Lee KS, et al
    Comparison of disease progression between brain-predominant Parkinson's disease versus Parkinson's disease with body-involvement phenotypes.
    Neurobiol Dis. 2022;174:105883.
    >> Share

  75. EVANS RC
    Dendritic involvement in inhibition and disinhibition of vulnerable dopaminergic neurons in healthy and pathological conditions.
    Neurobiol Dis. 2022;172:105815.
    >> Share

    September 2022
  76. MARTEL AC, Galvan A
    Connectivity of the corticostriatal and thalamostriatal systems in normal and parkinsonian states: An update.
    Neurobiol Dis. 2022;174:105878.
    >> Share

  77. RUF WP, Palmer A, Dorfer L, Wiesner D, et al
    Thoracic trauma promotes alpha-Synuclein oligomerization in murine Parkinson's disease.
    Neurobiol Dis. 2022 Sep 23:105877. doi: 10.1016/j.nbd.2022.105877.
    >> Share

  78. ZANG NAM, Schneider M, Weiss D
    Cortical mechanisms of movement recovery after freezing in Parkinson's disease.
    Neurobiol Dis. 2022;174:105871.
    >> Share

  79. STOLL AC, Sortwell CE
    Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicity.
    Neurobiol Dis. 2022;171:105804.
    >> Share

    August 2022
  80. IMBRIANI P, Martella G, Bonsi P, Pisani A, et al
    Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease.
    Neurobiol Dis. 2022 Aug 22:105851. doi: 10.1016/j.nbd.2022.105851.
    >> Share

  81. OUN A, Sabogal-Guaqueta AM, Galuh S, Alexander A, et al
    The multifaceted role of LRRK2 in Parkinson's disease: From human iPSC to organoids.
    Neurobiol Dis. 2022 Aug 10:105837. doi: 10.1016/j.nbd.2022.105837.
    >> Share

  82. WILLIAMS ET, Chen X, Otero PA, Moore DJ, et al
    Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.
    Neurobiol Dis. 2022;170:105768.
    >> Share

  83. ERDMAN HB, Kornilov E, Kahana E, Zarchi O, et al
    Asleep DBS under ketamine sedation: Proof of concept.
    Neurobiol Dis. 2022;170:105747.
    >> Share

    July 2022
  84. BICHSEL O, Stieglitz L, Oertel M, Baumann C, et al
    The modulatory effect of self-paced and cued motor execution on subthalamic beta-bursts in Parkinson's disease: Evidence from deep brain recordings in humans.
    Neurobiol Dis. 2022;172:105818.
    >> Share

  85. TIAN Y, Pan L, Yuan X, Xiong M, et al
    7,8-Dihydroxyflavone ameliorates mitochondrial impairment and motor dysfunction in the alpha-synuclein 1-103 transgenic mice.
    Neurobiol Dis. 2022;169:105736.
    >> Share

  86. RUSSO I, Bubacco L, Greggio E
    LRRK2 as a target for modulating immune system responses.
    Neurobiol Dis. 2022;169:105724.
    >> Share

  87. BURMEISTER AR, Gordevicius J, Paul EN, Houck C, et al
    Maternal Herpesviridae infection during pregnancy alters midbrain dopaminergic signatures in adult offspring.
    Neurobiol Dis. 2022;169:105720.
    >> Share

  88. PAMIES D, Wiersma D, Katt ME, Zhao L, et al
    Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity.
    Neurobiol Dis. 2022;169:105719.
    >> Share

    June 2022
  89. TSAFARAS G, Baekelandt V
    The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseases.
    Neurobiol Dis. 2022 Jun 30:105806. doi: 10.1016/j.nbd.2022.105806.
    >> Share

  90. O'HANLON ME, Tweedy C, Scialo F, Bass R, et al
    Mitochondrial electron transport chain defects modify Parkinson's disease phenotypes in a Drosophila model.
    Neurobiol Dis. 2022 Jun 25:105803. doi: 10.1016/j.nbd.2022.105803.
    >> Share

  91. MANTIA K, Kostas V, Katerina M
    The promise of the TGF-beta superfamily as a therapeutic target for Parkinson's disease.
    Neurobiol Dis. 2022 Jun 25:105805. doi: 10.1016/j.nbd.2022.105805.
    >> Share

  92. RAUSCHENBERGER L, Behnke J, Grotemeyer A, Knorr S, et al
    Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated alpha-synuclein mouse model of Parkinson's disease.
    Neurobiol Dis. 2022 Jun 21:105798. doi: 10.1016/j.nbd.2022.105798.
    >> Share

  93. KIM J, Lee J, Kim E, Choi JH, et al
    Dopamine depletion can be predicted by the aperiodic component of subthalamic local field potentials.
    Neurobiol Dis. 2022;168:105692.
    >> Share

    May 2022
  94. VOIGT RM, Wang Z, Brown JM, Engen PA, et al
    Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.
    Neurobiol Dis. 2022 May 30:105780. doi: 10.1016/j.nbd.2022.105780.
    >> Share

  95. SONG B, Feldmann JW, Cao S, Feitosa M, et al
    A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease.
    Neurobiol Dis. 2022 May 27:105777. doi: 10.1016/j.nbd.2022.105777.
    >> Share

  96. ABDI IY, Ghanem SS, El-Agnaf OM
    Immune-related biomarkers for Parkinson's disease.
    Neurobiol Dis. 2022;170:105771.
    >> Share

  97. KEENEY MT, Hoffman EK, Farmer K, Bodle CR, et al
    NADPH oxidase 2 activity in Parkinson's disease.
    Neurobiol Dis. 2022 May 13:105754. doi: 10.1016/j.nbd.2022.105754.
    >> Share

  98. BARTL M, Xylaki M, Bahr M, Weber S, et al
    Evidence for immune system alterations in peripheral biological fluids in Parkinson's disease.
    Neurobiol Dis. 2022 May 2:105744. doi: 10.1016/j.nbd.2022.105744.
    >> Share

  99. IZCO M, Carlos E, Alvarez-Erviti L
    Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases.
    Neurobiol Dis. 2022;166:105651.
    >> Share

    April 2022
  100. MAMAIS A, Kaganovich A, Harvey K
    Convergence of signalling pathways in innate immune responses and genetic forms of Parkinson's disease.
    Neurobiol Dis. 2022;169:105721.
    >> Share

    March 2022
  101. CAMPANELLI F, Natale G, Marino G, Ghiglieri V, et al
    Striatal glutamatergic hyperactivity in Parkinson's disease.
    Neurobiol Dis. 2022 Mar 18:105697. doi: 10.1016/j.nbd.2022.105697.
    >> Share

  102. WEISS F, Labrador-Garrido A, Dzamko N, Halliday G, et al
    Immune responses in the Parkinson's disease brain.
    Neurobiol Dis. 2022;168:105700.
    >> Share

  103. HENDERSON MX, Henrich MT, Geibl FF, Oertel WH, et al
    The roles of connectivity and neuronal phenotype in determining the pattern of alpha-synuclein pathology in Parkinson's disease.
    Neurobiol Dis. 2022 Mar 10:105687. doi: 10.1016/j.nbd.2022.105687.
    >> Share

  104. SHEN W, Zhai S, Surmeier DJ
    Striatal synaptic adaptations in Parkinson's disease.
    Neurobiol Dis. 2022 Mar 7:105686. doi: 10.1016/j.nbd.2022.105686.
    >> Share

  105. COUSINEAU J, Plateau V, Baufreton J, Le Bon-Jego M, et al
    Dopaminergic modulation of primary motor cortex: From cellular and synaptic mechanisms underlying motor learning to cognitive symptoms in Parkinson's disease.
    Neurobiol Dis. 2022 Mar 1:105674. doi: 10.1016/j.nbd.2022.105674.
    >> Share

    February 2022
  106. MOLINET-DRONDA F, Blesa J, Del Rey NL, Juri C, et al
    Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism.
    Neurobiol Dis. 2022;167:105669.
    >> Share

  107. BOCCALINI C, Carli G, Pilotto A, Padovani A, et al
    Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes.
    Neurobiol Dis. 2022;167:105668.
    >> Share

  108. GEGG ME, Menozzi E, Schapira AHV
    Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments.
    Neurobiol Dis. 2022;166:105663.
    >> Share

  109. KASEN A, Houck C, Burmeister AR, Sha Q, et al
    Upregulation of alpha-synuclein following immune activation: Possible trigger of Parkinson's disease.
    Neurobiol Dis. 2022 Feb 7:105654. doi: 10.1016/j.nbd.2022.105654.
    >> Share

    January 2022
  110. HORSAGER J, Knudsen K, Sommerauer M
    Clinical and imaging evidence of brain-first and body-first Parkinson's disease.
    Neurobiol Dis. 2022 Jan 11:105626. doi: 10.1016/j.nbd.2022.105626.
    >> Share

  111. WOERMAN AL, Tamguney G
    Body-first Parkinson's disease and variant Creutzfeldt-Jakob disease - similar or different?
    Neurobiol Dis. 2022 Jan 10:105625. doi: 10.1016/j.nbd.2022.105625.
    >> Share

    December 2021
  112. LI J, Chen L, Qin Q, Wang D, et al
    Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson's disease.
    Neurobiol Dis. 2021;163:105605.
    >> Share

  113. CHEN H, Wang K, Scheperjans F, Killinger B, et al
    Environmental triggers of Parkinson's disease - Implications of the Braak and dual-hit hypotheses.
    Neurobiol Dis. 2021;163:105601.
    >> Share

  114. VAN DEN BERGE N, Ulusoy A
    Animal models of brain-first and body-first Parkinson's disease.
    Neurobiol Dis. 2021;163:105599.
    >> Share

  115. SCHILDER BM, Navarro E, Raj T
    Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms.
    Neurobiol Dis. 2021 Dec 3:105580. doi: 10.1016/j.nbd.2021.105580.
    >> Share

  116. NOVELLO S, Mercatelli D, Albanese F, Domenicale C, et al
    In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity.
    Neurobiol Dis. 2021 Dec 3:105579. doi: 10.1016/j.nbd.2021.105579.
    >> Share

  117. BORGHAMMER P, Horsager J, Andersen K, Van Den Berge N, et al
    Neuropathological evidence of body-first vs. brain-first Lewy body disease.
    Neurobiol Dis. 2021;161:105557.
    >> Share

    November 2021
  118. HANG L, Wang Z, Foo ASC, Goh GWY, et al
    Conditional disruption of AMP kinase in dopaminergic neurons promotes Parkinson's disease-associated phenotypes in vivo.
    Neurobiol Dis. 2021;161:105560.
    >> Share

  119. NORDSTROM E, Eriksson F, Sigvardson J, Johannesson M, et al
    ABBV-0805, a novel antibody selective for soluble aggregated alpha-synuclein, prolongs lifespan and prevents buildup of alpha-synuclein pathology in mouse models of Parkinson's disease.
    Neurobiol Dis. 2021 Nov 1:105543. doi: 10.1016/j.nbd.2021.105543.
    >> Share

  120. FERRER-RAVENTOS P, Beyer K
    Alternative platelet activation pathways and their role in neurodegenerative diseases.
    Neurobiol Dis. 2021;159:105512.
    >> Share

  121. JOHNSON ME, Bergkvist L, Stetzik L, Steiner JA, et al
    Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological alpha-synuclein spread in the prodromal preformed fibrils model in young mice.
    Neurobiol Dis. 2021;159:105513.
    >> Share

  122. COSDEN M, Jinn S, Yao L, Gretzula CA, et al
    A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.
    Neurobiol Dis. 2021;159:105507.
    >> Share

  123. BRENDZA R, Lin H, Stark K, Foreman O, et al
    Genetic ablation of Gpnmb does not alter synuclein-related pathology.
    Neurobiol Dis. 2021;159:105494.
    >> Share

  124. ALBANESE F, Mercatelli D, Finetti L, Lamonaca G, et al
    Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo.
    Neurobiol Dis. 2021;159:105487.
    >> Share

    October 2021
  125. HU S, Tan J, Qin L, Lv L, et al
    Molecular chaperones and Parkinson's disease.
    Neurobiol Dis. 2021;160:105527.
    >> Share

    August 2021
  126. ALANAZI FI, Al-Ozzi T, Kalia SK, Hodaie M, et al
    Neurophysiological responses of globus pallidus internus during the auditory oddball task in Parkinson's disease.
    Neurobiol Dis. 2021 Aug 27:105490. doi: 10.1016/j.nbd.2021.105490.
    >> Share

  127. TORRES ERS, Stanojlovic M, Zelikowsky M, Bonsberger J, et al
    Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease.
    Neurobiol Dis. 2021;158:105478.
    >> Share

  128. ARKAN S, Ljungberg M, Kirik D, Hansen C, et al
    DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson's disease.
    Neurobiol Dis. 2021 Aug 11:105477. doi: 10.1016/j.nbd.2021.105477.
    >> Share

  129. OLSEN AL, Feany MB
    Parkinson's disease risk genes act in glia to control neuronal alpha-synuclein toxicity.
    Neurobiol Dis. 2021 Aug 11:105482. doi: 10.1016/j.nbd.2021.105482.
    >> Share

  130. RODICHKIN AN, Edler MK, McGlothan JL, Guilarte TR, et al
    Behavioral and neurochemical studies of inherited manganese-induced dystonia-parkinsonism in Slc39a14-knockout mice.
    Neurobiol Dis. 2021 Aug 3:105467. doi: 10.1016/j.nbd.2021.105467.
    >> Share

    July 2021
  131. KAKUSA B, Huang Y, Barbosa DAN, Feng A, et al
    Anticipatory human subthalamic area beta-band power responses to dissociable tastes correlate with weight gain.
    Neurobiol Dis. 2021;154:105348.
    >> Share

    June 2021
  132. ANDREOLI L, Abbaszadeh M, Cao X, Cenci MA, et al
    Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism.
    Neurobiol Dis. 2021 Jun 18:105429. doi: 10.1016/j.nbd.2021.105429.
    >> Share

    May 2021
  133. FAUSER M, Ricken M, Markert F, Weis N, et al
    Subthalamic nucleus deep brain stimulation induces sustained neurorestoration in the mesolimbic dopaminergic system in a Parkinson's disease model.
    Neurobiol Dis. 2021 May 24:105404. doi: 10.1016/j.nbd.2021.105404.
    >> Share

  134. TOMKINS JE, Manzoni C
    Advances in protein-protein interaction network analysis for Parkinson's disease.
    Neurobiol Dis. 2021;155:105395.
    >> Share

  135. BRAZHNIK E, Novikov N, McCoy AJ, Ilieva NM, et al
    Early decreases in cortical mid-gamma peaks coincide with the onset of motor deficits and precede exaggerated beta build-up in rat models for Parkinson's disease.
    Neurobiol Dis. 2021 May 14:105393. doi: 10.1016/j.nbd.2021.105393.
    >> Share

  136. WESTON LJ, Cook ZT, Stackhouse TL, Sal MK, et al
    In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129.
    Neurobiol Dis. 2021;152:105291.
    >> Share

  137. WIEST C, Tinkhauser G, Pogosyan A, He S, et al
    Subthalamic deep brain stimulation induces finely-tuned gamma oscillations in the absence of levodopa.
    Neurobiol Dis. 2021;152:105287.
    >> Share

    April 2021
  138. YIN Z, Zhu G, Zhao B, Bai Y, et al
    Local field potentials in Parkinson's disease: a frequency-based review.
    Neurobiol Dis. 2021 Apr 28:105372. doi: 10.1016/j.nbd.2021.105372.
    >> Share

  139. PETERS OM, Weiss A, Metterville J, Song L, et al
    Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease.
    Neurobiol Dis. 2021 Apr 20:105368. doi: 10.1016/j.nbd.2021.105368.
    >> Share

    March 2021
  140. BRUMBERG J, Kuzkina A, Lapa C, Mammadova S, et al
    Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy.
    Neurobiol Dis. 2021 Mar 12:105332. doi: 10.1016/j.nbd.2021.105332.
    >> Share

  141. CHU Y, Kordower JH
    GDNF signaling in subjects with minimal motor deficits and Parkinson's disease.
    Neurobiol Dis. 2021 Mar 5:105298. doi: 10.1016/j.nbd.2021.105298.
    >> Share

  142. ZOU L, Zhang X, Xiong M, Meng L, et al
    Asparagine endopeptidase cleaves synaptojanin 1 and triggers synaptic dysfunction in Parkinson's disease.
    Neurobiol Dis. 2021 Mar 4:105326. doi: 10.1016/j.nbd.2021.105326.
    >> Share

  143. CREED RB, Roberts RC, Farmer CB, McMahon LL, et al
    Increased glutamate transmission onto dorsal striatum spiny projection neurons in Pink1 knockout rats.
    Neurobiol Dis. 2021;150:105246.
    >> Share

    February 2021
  144. JIANG M, Tu HT, Zhang K, Zhang W, et al
    Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson's disease through interaction with APP.
    Neurobiol Dis. 2021 Feb 23:105313. doi: 10.1016/j.nbd.2021.105313.
    >> Share

  145. DE MIRANDA BR, Castro SL, Rocha EM, Bodle CR, et al
    The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's disease.
    Neurobiol Dis. 2021 Feb 23:105312. doi: 10.1016/j.nbd.2021.105312.
    >> Share

  146. KINNERUP MB, Sommerauer M, Damholdt MF, Schaldemose JL, et al
    Preserved noradrenergic function in Parkinson's disease patients with rest tremor.
    Neurobiol Dis. 2021 Feb 4:105295. doi: 10.1016/j.nbd.2021.105295.
    >> Share

    January 2021
  147. SENCHUK MM, Van Raamsdonk JM, Moore DJ
    Multiple genetic pathways regulating lifespan extension are neuroprotective in a G2019S LRRK2 nematode model of Parkinson's disease.
    Neurobiol Dis. 2021 Jan 12:105267. doi: 10.1016/j.nbd.2021.105267.
    >> Share

  148. BLAUWENDRAAT C, Makarious MB, Leonard HL, Bandres-Ciga S, et al
    A population scale analysis of rare SNCA variation in the UK Biobank.
    Neurobiol Dis. 2021;148:105182.
    >> Share

  149. ANTONAZZO M, Gomez-Urquijo SM, Ugedo L, Morera-Herreras T, et al
    Dopaminergic denervation impairs cortical motor and associative/limbic information processing through the basal ganglia and its modulation by the CB1 receptor.
    Neurobiol Dis. 2021;148:105214.
    >> Share

    December 2020
  150. YANG J, Luo S, Zhang J, Yu T, et al
    Exosome-mediated delivery of antisense oligonucleotides targeting alpha-synuclein ameliorates the pathology in a mouse model of Parkinson's disease.
    Neurobiol Dis. 2020 Dec 6:105218. doi: 10.1016/j.nbd.2020.105218.
    >> Share

    November 2020
  151. ARASARATNAM CJ, Singh-Bains MK, Waldvogel HJ, Faull RLM, et al
    Neuroimaging and neuropathology studies of X-linked dystonia parkinsonism.
    Neurobiol Dis. 2020;148:105186.
    >> Share

  152. AGLIARDI C, Meloni M, Guerini FR, Zanzottera M, et al
    Oligomeric alpha-Syn and SNARE complex proteins in peripheral extracellular vesicles of neural origin are biomarkers for Parkinson's disease.
    Neurobiol Dis. 2020 Nov 17:105185. doi: 10.1016/j.nbd.2020.105185.
    >> Share

  153. UNDERWOOD CF, Parr-Brownlie LC
    Primary motor cortex in Parkinson's disease: Functional changes and opportunities for neurostimulation.
    Neurobiol Dis. 2020 Nov 2:105159. doi: 10.1016/j.nbd.2020.105159.
    >> Share

    October 2020
  154. WILKINS KB, Parker JE, Bronte-Stewart HM
    Gait variability is linked to the atrophy of the Nucleus Basalis of Meynert and is resistant to STN DBS in Parkinson's disease.
    Neurobiol Dis. 2020;146:105134.
    >> Share

    September 2020
  155. BAASKE MK, Kormann E, Holt AB, Gulberti A, et al
    Parkinson's disease uncovers an underlying sensitivity of subthalamic nucleus neurons to beta-frequency cortical input in vivo.
    Neurobiol Dis. 2020 Sep 26:105119. doi: 10.1016/j.nbd.2020.105119.
    >> Share

    June 2020
  156. ZHENG C, Xu Y, Chen G, Tan Y, et al
    Distinct anti-dyskinetic effects of amantadine and group II metabotropic glutamate receptor agonist LY354740 in a rodent model: An electrophysiological perspective.
    Neurobiol Dis. 2020;139:104807.
    >> Share

  157. PELLEGRINI C, Ippolito C, Segnani C, Dolfi A, et al
    Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration.
    Neurobiol Dis. 2020;139:104821.
    >> Share

  158. ANAND N, Holcom A, Broussalian M, Schmidt M, et al
    Dysregulated iron metabolism in C. elegans catp-6/ATP13A2 mutant impairs mitochondrial function.
    Neurobiol Dis. 2020;139:104786.
    >> Share

    May 2020
  159. FAUSTINI G, Longhena F, Bruno A, Bono F, et al
    Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.
    Neurobiol Dis. 2020;138:104789.
    >> Share

    April 2020
  160. VINUEZA-GAVILANES R, Inigo-Marco I, Larrea L, Lasa M, et al
    N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity.
    Neurobiol Dis. 2020;137:104781.
    >> Share

  161. BAASKE MK, Kramer ER, Meka DP, Engler G, et al
    Parkin deficiency perturbs striatal circuit dynamics.
    Neurobiol Dis. 2020;137:104737.
    >> Share

    February 2020
  162. STOYKA LE, Arrant AE, Thrasher DR, Russell DL, et al
    Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded alpha-synuclein inclusions.
    Neurobiol Dis. 2020;134:104708.
    >> Share

  163. AFGHAH Z, Chen X, Geiger JD
    Role of endolysosomes and inter-organellar signaling in brain disease.
    Neurobiol Dis. 2020;134:104670.
    >> Share

  164. CHEN C, Vincent AE, Blain AP, Smith AL, et al
    Investigation of mitochondrial biogenesis defects in single substantia nigra neurons using post-mortem human tissues.
    Neurobiol Dis. 2020;134:104631.
    >> Share

  165. ALBERQUILLA S, Gonzalez-Granillo A, Martin ED, Moratalla R, et al
    Dopamine regulates spine density in striatal projection neurons in a concentration-dependent manner.
    Neurobiol Dis. 2020;134:104666.
    >> Share

  166. SOLTI K, Kuan WL, Forizs B, Kustos G, et al
    DJ-1 can form beta-sheet structured aggregates that co-localize with pathological amyloid deposits.
    Neurobiol Dis. 2020;134:104629.
    >> Share

  167. YANG SY, Gegg M, Chau D, Schapira A, et al
    Glucocerebrosidase activity, cathepsin D and monomeric alpha-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation.
    Neurobiol Dis. 2020;134:104620.
    >> Share

  168. MEZIAS C, Rey N, Brundin P, Raj A, et al
    Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation.
    Neurobiol Dis. 2020;134:104623.
    >> Share

  169. CRESTO N, Gaillard MC, Gardier C, Gubinelli F, et al
    The C-terminal domain of LRRK2 with the G2019S mutation is sufficient to produce neurodegeneration of dopaminergic neurons in vivo.
    Neurobiol Dis. 2020;134:104614.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016